Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Asset Utilization Ratio (2021 - 2022)

Atea Pharmaceuticals (AVIR) has 2 years of Asset Utilization Ratio data on record, last reported at 0.28 in Q3 2022.

  • For Q3 2022, Asset Utilization Ratio rose 49.94% year-over-year to 0.28; the TTM value through Sep 2022 reached 0.28, up 49.94%, while the annual FY2021 figure was 0.43, N/A changed from the prior year.
  • Asset Utilization Ratio reached 0.28 in Q3 2022 per AVIR's latest filing, down from 0.32 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.43 in Q4 2021 and bottomed at 0.08 in Q1 2021.